1. Home
  2. AEHL vs ENSC Comparison

AEHL vs ENSC Comparison

Compare AEHL & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEHL

Antelope Enterprise Holdings Limited

HOLD

Current Price

$0.51

Market Cap

2.0M

Sector

Industrials

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.38

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHL
ENSC
Founded
1993
2003
Country
China
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
1.7M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
AEHL
ENSC
Price
$0.51
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
285.1K
217.2K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$55.01
Revenue Next Year
N/A
$1,033.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.31
52 Week High
$6.53
$2.75

Technical Indicators

Market Signals
Indicator
AEHL
ENSC
Relative Strength Index (RSI) 30.20 39.10
Support Level $0.48 $0.31
Resistance Level $1.46 $0.63
Average True Range (ATR) 0.07 0.04
MACD -0.01 -0.01
Stochastic Oscillator 6.92 22.62

Price Performance

Historical Comparison
AEHL
ENSC

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: